Featured Research

from universities, journals, and other organizations

New Approach Promises Greater Success For Predicting Drug Safety

Date:
May 11, 2009
Source:
University of North Carolina School of Medicine
Summary:
Scientists describes a new, more effective and less costly method for testing drugs for potential toxicity and one that could also result in more people benefiting from existing drugs.

Adverse reactions to drugs represent one of the leading causes of death in the United States. But there may be a way to predict who is most likely to suffer a toxic side effect to a drug before they have even taken it.

A study published online in the journal Genome Research describes a new, more effective and less costly method for testing drugs for potential toxicity and one that could also result in more people benefiting from existing drugs, said senior author David Threadgill, Ph.D., professor of genetics in the University of North Carolina at Chapel Hill School of Medicine. He also heads the genetics department at North Carolina State University.

Drug safety has become the major bottleneck in getting new drugs to patients, said Paul Watkins, M.D., distinguished professor of medicine at UNC and study co-author. Over the last several years, the pharmaceutical industry has made progress in developing drugs that are likely to work, but sometimes potentially deadly effects still do not emerge until they are on the market. In the case of Vioxx, millions of people had already used the pain-killer and arthritis medication before researchers found it could increase the risk of having a heart attack or stroke.

“The reality is that there is no safe drug,” Watkins said. “Good drugs are bad for some people. Because different people respond differently to drugs, where you draw the line is not exactly black and white.”

But Watkins also argues that while drugs currently on the market are not entirely safe, they are harmless in 99.9 percent of people . Therefore, if it were possible to identify in advance the one person in 1000 that will react poorly, scientists could make drugs that are safe for everybody.

With that purpose in mind, Threadgill, Watkins and a team of researchers created a new testing method that exploit the genetic similarities between mice and humans. The researchers took a group of mice that were genetically distinct from each other and looked to see if variations in their genetic makeup could predict their response to treatment with acetaminophen (the chemical component of Tylenol and which is extensively used in liver toxicity studies). The mice were bred at the Jackson Laboratory in Bar Harbor, Maine.

After identifying many genes that were associated with side effects to acetaminophen in their mouse models, Threadgill and his colleagues then went back to humans to see which of these gene variants were also associated with response to the drug.

The researchers found that a subset of people taking the maximum daily recommended dose of the drug exhibited an elevation in specific enzymes that can indicate damage to the liver, Threadgill said. Variations in one gene in particular – called CD44 – were responsible for almost half of the differences in toxic side effects experienced from one person to another.

“One of the fascinating things that came out of this study was that the genetic variation in acetaminophen toxicity is not what all of the toxicologists would have predicted in the first place,” said study co-author Ken Paigen, Ph.D., Jackson Laboratory executive research fellow. “CD44 doesn’t have anything to do with the rate of metabolism of the drug, but it does have something to do with the immune response.”

In effect, the study has created a system that enables researchers to gather interesting clues about what makes some people susceptible to drug toxicity and then explore them in mouse models. But the team believes perhaps the greatest impact this research could have is to improve the drug development process – to begin to understand what properties of a drug can make it toxic, and to identify the people most vulnerable to those toxicities.

“Just look at the drug industry’s own numbers on how much it costs to develop a drug,” said Threadgill. “To get a drug to the market takes close to $1 billion, whereas a study like this can be done for $100,000. This approach could be used to determine early on if the drug is not going to be viable because of a high level of toxicity, or it could give important insights into whether the drug is likely to be beneficial.”

Study co-authors at UNC include Alison H. Harrill, Ph.D., the lead author and former graduate student, now a postdoctoral fellow at the Hamner Institutes for Health Sciences; Pamela K. Ross, research technician; David E. Harbourt, graduate student; Mark W. Russo, M.D., former research fellow in the division of gastroenterology and hepatology; Philip C. Smith, Ph.D., associate professor of molecular pharmaceutics; Timothy Wiltshire, Ph.D., associate professor of pharmacotherapy and experimental therapeutics; and Ivan Rusyn, M.D., Ph.D., associate professor of environmental sciences and engineering in the UNC Gillings School of Global Public Health.

The following laboratories also contributed to the study: the National Institute of Environmental Health Sciences in Research Triangle Park, N.C.; Jackson Laboratory in Bar Harbor, Maine; Verto Institute Research Laboratories and Cancer Institute of New Jersey, both in New Brunswick, N.J.; Novartis Institute in San Diego, Calif.; Purdue Pharma L.P. in Stamford, Conn.; and the department of genetics at North Carolina State University in Raleigh.

The research was funded by the National Institutes of Health.


Story Source:

The above story is based on materials provided by University of North Carolina School of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

University of North Carolina School of Medicine. "New Approach Promises Greater Success For Predicting Drug Safety." ScienceDaily. ScienceDaily, 11 May 2009. <www.sciencedaily.com/releases/2009/05/090504171951.htm>.
University of North Carolina School of Medicine. (2009, May 11). New Approach Promises Greater Success For Predicting Drug Safety. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2009/05/090504171951.htm
University of North Carolina School of Medicine. "New Approach Promises Greater Success For Predicting Drug Safety." ScienceDaily. www.sciencedaily.com/releases/2009/05/090504171951.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins